Latest AI and machine learning research in hypertension for healthcare professionals.
Hypertension (HTN) is a major contributor to cardiovascular (CV) morbidity and mortality. Its heterogeneity complicates risk stratification. Unsupervised machine learning can identify risk profiles and refine preventative strategies. This study applies clustering analysis to clinical data to identify HTN phenogroups and their link with CV abnormalities and outcomes. 14,840 UK Biobank participants ...
Hypertension is a leading global health concern, significantly contributing to cardiovascular, cerebrovascular, and renal diseases. In critically ill patients, hypertension poses increased risks of complications and mortality. Early and accurate mortality prediction in this population is essential for timely intervention and improved outcomes. Machine learning (ML) and deep learning (DL) approache...
Carotid stenosis, which is atherosclerotic narrowing of the extracranial carotid arteries, is an important risk factor for ischemic stroke. The preval...
To develop a segmentation and quality control pipeline for short-axis cardiac magnetic resonance (CMR) cine images from the prospective, multi-center ...
Hypertension is a major risk factor for cardiovascular diseases. This study proposes a novel hypertension screening framework based on awake-sleep dif...
Alzheimer’s disease (AD) is a complex neurodegenerative disorder with limited therapeutic options. The original DeepDrug framework by Li et al. (2025)...
Left ventricular diastolic dysfunction (LVDD) is most commonly evaluated by echocardiography. However, without a sole identifying metric, LVDD is asse...
Prolonged fasting may benefit metabolic health, but data in healthy individuals remain limited. We performed a randomized, waitlist-controlled study (...
Dementia, especially Alzheimer’s disease (AD), is a major global health challenge marked by progressive cognitive impairment, behavioral changes, and ...
Target Trial Emulation (TTE) has emerged as a rigorous framework for causal inference using observational data, but its application in hypertension re...
Load-independent indices of right ventricular (RV) dysfunction aid in the prognosis of patients with pulmonary hypertension (PH), but their acquisitio...
Artificial intelligence (AI) models can now detect patterns of structural heart diseases (SHDs) from electrocardiograms (ECGs), though scaling them re...
With rapid urbanization, lifestyle changes, and an aging population, non-communicable diseases (NCDs), including hypertension and diabetes, pose signi...
Free-running (FR) cardiac MRI enables free-breathing ECG-free fully dynamic 5D (3D spatial+cardiac+respiration dimensions) imaging but poses significa...
In cardiovascular magnetic resonance (CMR), myocardial native T1 mapping enables quantitative, non-invasive tissue characterization and is sensitive t...
Medication non-adherence remains a significant challenge in managing chronic conditions like diabetes and hypertension, leading to increased morbidity...
Hepatic steatosis (HS) is a common cardiometabolic risk factor frequently present but under-diagnosed in patients with suspected or known coronary art...
Determination of cardiac output (CO) is essential to the clinical management of cardiovascular compromise. However, the invasiveness, procedural risks...
Stroke is one of the leading causes of death and long-term disability globally. Several studies have investigated the incidence and predictors of stro...
Cardiovascular disease (CVD) remains the foremost contributor to global illness and death, underscoring the critical need for effective tools that can...